Korea refines rules for safe, swift approval of biopharmaceuticals
New rules being considered by South Korea’s Ministry of Food and Drug Safety (MFDS) would make it easier to investigate the safety of high-tech cell therapies and genetic treatments, as well as other biopharmaceutical products, before they are approved. The new screening... Read More